Predicting Prognosis and Treatment Response in Subset of Pancreatic Cancer Patients Posted Date: 2/11/2010 UCLA Faculty: David Dawson, M.D., Ph.D. Specific chemical modifications to proteins called histones, which are found […]
Hirshberg Foundation Awards and Grants 2010
We are pleased to announce the selection of 2010-2011 Hirshberg Foundation for Pancreatic Cancer Research Seed Grant Award recipients. The purpose of our seed grant program is to impact the […]
UCLA Surgeons Identify Molecular Pathway That May Help Target Future Therapies Against Tumor Angiogenesis
UCLA SURGEONS IDENTIFY MOLECULAR PATHWAY THAT MAY HELP TARGET FUTURE THERAPIES AGAINST TUMOR ANGIOGENESIS Study provides a new look at molecular contributors to angiogenesis CHICAGO—Researchers at the University of California […]
Metformin reduces the growth of pancreatic cancer
Metformin (Glucophag) reduces the growth of pancreatic cancer Investigators supported by the Hirshberg Foundation, including dr Kisfalvi (a recipient of a seed grant from the Foundation), Dr. Eibl (Hirshberg […]
Risk of Pancreatic Cancer Linked to Variation in Gene that Determines Blood Type
From: http://www.cancer.gov/newscenter/pressreleases/ABOvariantPanScan Risk of Pancreatic Cancer Linked to Variation in Gene that Determines Blood Type Common variants of the gene that determines human blood type are associated with an increased […]
Phase One Clinical Trial
The Macrobead Phase One Clinical Trial 1/4/2008 Click for Summary